Drreddys Laboratories | RDY - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
ANI Pharmaceuticals USD 143.88M 19.7M 2026-03
Aurora Cannabis CAD 29.79M 16.83M 2026-03
Bayer EUR 6.33B 1.84B 2026-06
Canopy Growth CAD 8.26M 13.2M 2026-03
Cipla INR 44.1B 5B 2026-06
Corcept Therapeutics USD 252.09M 90.07M 2026-06
Drreddys Laboratories INR 43.04B 3.77B 2026-03
GlaxoSmithKline GBP 6.51B 757M 2026-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lonza CHF 1.29B 248M 2025-06
Novartis USD 11.24B 1.18B 2026-06
Pacira USD 133.91M 7.27M 2026-06
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 136.19M 10.11M 2026-06
Richter Gedeon HUF 143.37B 25.78B 2025-09
Sun Pharmaceuticals INR 117.59B 7.65B 2026-03
Supernus Pharmaceuticals USD 160.06M 30.7M 2026-06
Teva Pharmaceutical Industries USD 2.15B 45M 2026-06